Financial statements Exim Pharma
Cash flow statement of Exim Pharma
Company age:
Age:
9 y. 10 m. 28 d.
Share capital:
Share capital:
5 000 PLN
Cash inflows of EXIM PHARMA
|
Year
|
2018
|
2019
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Net cash from operating expenses | - | - | - | 6 999 953,79 | 15 040 364,96 |
| Net cash flow from investing activities | - | - | - | -6 974 602,51 | -6 563 093,19 |
| Net cash flow from financial activities | - | - | - | 957 024,81 | 1 160 114,47 |
| Total net cash flow | - | - | - | 982 376,09 | 9 637 386,24 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.